OpenVSafe by OpenVAERS
Search V-safe

ATC-38607-29309

1 vaccination 6 coded responses 6 check-ins 6 free-text entries 5 call cases
Sex
Female
Age at first dose
21-25
ZIP prefix
330 / FL
Registered
2021-01-07
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-28
    Dose 1 — Moderna
  2. 2021-01-07
    Registered in v-safe
  3. 2021-01-07
    Survey response — day 7, dose 1
    MedDRA: Auditory nerve disorder, Sudden hearing loss, Vestibular neuronitis — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Be unable to work, Be unable to do your normal daily activities
    Free text: Sudden hearing loss due to inflammation of auditory nerve in right ear on January 6th
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-07
    Report sent to call center — day 7, dose 1
    Be unable to work · Be unable to do your normal daily activities
    no matching call case
  5. 2021-01-19
    Survey response — day 21, dose 1
    MedDRA: Deafness neurosensory, Hyperacusis, Tinnitus — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Tinnitus, hyperacusis post sudden sensorineural hearing loss
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-01-19
    Report sent to call center — day 21, dose 1
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  7. 2021-01-25
    Survey response — day 28, dose 1
    MedDRA: Deafness unilateral, Tinnitus — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Recovering from sudden hearing loss of 30 decibels across frequencies in right ear, continued tinnitus
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-01-25
    Report sent to call center — day 28, dose 1
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  9. 2021-02-01
    Survey response — day 35, dose 1
    MedDRA: Deafness neurosensory, Tinnitus — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Recovering from sudden sensorineural hearing loss. Continued tinnitus.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-02-01
    Report sent to call center — day 35, dose 1
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  11. 2021-02-10
    Survey response — day 42, dose 1
    MedDRA: Deafness neurosensory, Tinnitus — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Recovering from sensorineural hearing loss. Continued tinnitus.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-02-10
    Report sent to call center — day 42, dose 1
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  13. 2021-03-29
    Survey response — 3 months, dose 1
    MedDRA: Deafness neurosensory, Tinnitus — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Tinnitus related to sensorineural hearing loss
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-03-29
    Report sent to call center — 3 months, dose 1
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  15. 2021-05-02
  16. 2021-05-04
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact

Vaccinations

DoseDateManufacturerCo-administered
12020-12-28Moderna

Call center

5 call center cases

5 successful

VAERS report filed, before or during a call: 5

1 check-in flagged for a call with no call center case on record

See the call center timeline

Free text

Release 1 — day 7, dose 1

2021-01-07

Systemic reaction (other): Sudden hearing loss due to inflammation of auditory nerve in right ear on January 6th

Release 2 — day 21, dose 1

2021-01-19

Symptoms: Tinnitus, hyperacusis post sudden sensorineural hearing loss

Release 2 — day 28, dose 1

2021-01-25

Symptoms: Recovering from sudden hearing loss of 30 decibels across frequencies in right ear, continued tinnitus

Release 3 — day 35, dose 1

2021-02-01

Symptoms: Recovering from sudden sensorineural hearing loss. Continued tinnitus.

Release 4 — day 42, dose 1

2021-02-10

Symptoms: Recovering from sensorineural hearing loss. Continued tinnitus.

Release 6 — 3 months, dose 1

2021-03-29

Symptoms: Tinnitus related to sensorineural hearing loss

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDeafness neurosensory ✓ ✓ ✓
SDDeafness unilateral ✓ ✓ ✓
SDHyperacusis ✓ ✓ ✓
SDTinnitus ✓ ✓ ✓
SROAuditory nerve disorder ○ ✓ ○
SROSudden hearing loss ✓ ✓ ✓
SROVestibular neuronitis ✓ · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release